Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $477,191 | 252 | 86.7% |
| Consulting Fee | $27,465 | 21 | 5.0% |
| Travel and Lodging | $25,088 | 267 | 4.6% |
| Food and Beverage | $20,158 | 809 | 3.7% |
| Education | $686.14 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $223,030 | 421 | $0 (2024) |
| GENZYME CORPORATION | $92,568 | 160 | $0 (2021) |
| Mallinckrodt Enterprises LLC | $39,554 | 64 | $0 (2019) |
| ABBVIE INC. | $35,294 | 121 | $0 (2024) |
| Allergan, Inc. | $32,629 | 98 | $0 (2021) |
| Amgen Inc. | $32,378 | 47 | $0 (2022) |
| Acorda Therapeutics, Inc | $29,394 | 63 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $19,856 | 143 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $16,390 | 90 | $0 (2020) |
| Biohaven Pharmaceuticals, Inc. | $11,584 | 16 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,430 | 88 | ABBVIE INC. ($570.59) |
| 2023 | $6,951 | 53 | Teva Pharmaceuticals USA, Inc. ($4,739) |
| 2022 | $59,581 | 118 | Teva Pharmaceuticals USA, Inc. ($23,977) |
| 2021 | $68,818 | 172 | Teva Pharmaceuticals USA, Inc. ($19,850) |
| 2020 | $72,466 | 126 | Teva Pharmaceuticals USA, Inc. ($38,025) |
| 2019 | $160,032 | 261 | Teva Pharmaceuticals USA, Inc. ($75,809) |
| 2018 | $98,504 | 246 | Teva Pharmaceuticals USA, Inc. ($41,289) |
| 2017 | $82,805 | 293 | GENZYME CORPORATION ($28,694) |
All Payment Transactions
1,357 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: PAIN | ||||||
| 12/17/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Neurology | ||||||
| 12/06/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Neuropsychiatry | ||||||
| 11/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Central Nervous System | ||||||
| 11/20/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Neurology | ||||||
| 11/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: Neurology | ||||||
| 11/18/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Neurology | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/01/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Central Nervous System | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: PAIN | ||||||
| 10/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.08 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Neurology | ||||||
| 10/11/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Central Nervous System | ||||||
| 09/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 718 | 817 | $267,558 | $66,844 |
| 2022 | 13 | 661 | 850 | $148,785 | $56,563 |
| 2021 | 12 | 750 | 961 | $162,849 | $65,687 |
| 2020 | 11 | 762 | 988 | $176,974 | $62,394 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 169 | 169 | $85,212 | $21,282 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 168 | $45,635 | $13,032 | 28.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 79 | 131 | $40,053 | $9,228 | 23.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 40 | 41 | $32,862 | $7,579 | 23.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 24 | 25 | $24,776 | $5,596 | 22.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 22 | 30 | $12,012 | $2,813 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 54 | $9,966 | $2,755 | 27.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 15 | 15 | $8,087 | $2,090 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $4,594 | $1,063 | 23.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 26 | 26 | $1,248 | $374.66 | 30.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 32 | 34 | $612.00 | $285.60 | 46.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 18 | 18 | $878.00 | $266.04 | 30.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 22 | 22 | $560.00 | $167.42 | 29.9% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 27 | 27 | $472.00 | $137.16 | 29.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 12 | 12 | $329.00 | $99.48 | 30.2% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 29 | 29 | $261.00 | $76.85 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 247 | 325 | $53,053 | $21,044 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 103 | 103 | $26,141 | $10,287 | 39.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 23 | 57 | $14,149 | $5,263 | 37.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 79 | 133 | $12,418 | $4,765 | 38.4% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 27 | 27 | $10,206 | $3,896 | 38.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 30 | 31 | $9,345 | $2,984 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 71 | $7,751 | $2,974 | 38.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $4,921 | $1,390 | 28.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 11 | 11 | $3,501 | $1,267 | 36.2% |
About Dr. John Dolan, D.O
Dr. John Dolan, D.O is a Neurology healthcare provider based in Portland, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467416800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Dolan, D.O has received a total of $550,588 in payments from pharmaceutical and medical device companies, with $1,430 received in 2024. These payments were reported across 1,357 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($477,191).
As a Medicare-enrolled provider, Dolan has provided services to 2,891 Medicare beneficiaries, totaling 3,616 services with total Medicare billing of $251,489. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Portland, ME
- Active Since 04/13/2006
- Last Updated 10/27/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1467416800
Products in Payments
- AUBAGIO (Drug) $92,176
- AUSTEDO (Drug) $59,791
- COPAXONE (Drug) $57,107
- AJOVY (Biological) $55,145
- AJOVY (Drug) $50,006
- UBRELVY (Drug) $49,092
- ACTHAR (Biological) $39,554
- Aimovig (Biological) $32,378
- INBRIJA (Drug) $29,024
- NURTEC ODT (Drug) $22,011
- INGREZZA (Drug) $16,889
- TROKENDI XR (Drug) $16,340
- NAMZARIC (Drug) $12,740
- QULIPTA (Drug) $5,473
- SOLIRIS (Drug) $2,814
- Soliris (Drug) $2,080
- ONGENTYS (Drug) $1,016
- Ongentys (Drug) $423.09
- LEMTRADA (Drug) $405.65
- VRAYLAR (Drug) $268.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Portland
Kyle Smoot, M.d, M.D
Neurology — Payments: $944,765
Stanley Cohan, M.d, M.D
Neurology — Payments: $664,935
Dr. Chafic Karam, M.d, M.D
Neurology — Payments: $647,064
Kiren Kresa-Reahl, M.d, M.D
Neurology — Payments: $421,575
Matthew Brodsky, Md, MD
Neurology — Payments: $244,252
David Spencer, Md, MD
Neurology — Payments: $101,259